These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 15467019

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. First-line therapies for lowering triglyceride levels.
    Raghavan VA.
    Am Fam Physician; 2008 Feb 15; 77(4):416; author reply 417-8. PubMed ID: 18326158
    [No Abstract] [Full Text] [Related]

  • 27. Managing dyslipidemia in chronic kidney disease.
    Harper CR, Jacobson TA.
    J Am Coll Cardiol; 2008 Jun 24; 51(25):2375-84. PubMed ID: 18565393
    [Abstract] [Full Text] [Related]

  • 28. The metabolic syndrome: targeting dyslipidaemia to reduce coronary risk.
    Ginsberg HN, Stalenhoef AF.
    J Cardiovasc Risk; 2003 Apr 24; 10(2):121-8. PubMed ID: 12668909
    [Abstract] [Full Text] [Related]

  • 29. The importance of recognizing and treating low levels of high-density lipoprotein cholesterol: a new era in atherosclerosis management.
    Cardenas GA, Lavie CJ, Cardenas V, Milani RV, McCullough PA.
    Rev Cardiovasc Med; 2008 Apr 24; 9(4):239-58. PubMed ID: 19122582
    [Abstract] [Full Text] [Related]

  • 30. [Therapy of dyslipidemia in post-infarction: state of the art].
    Borgia MC, Nardi M, Da Ros S, Castellano V.
    Clin Ter; 2007 Apr 24; 158(6):523-32. PubMed ID: 18265719
    [Abstract] [Full Text] [Related]

  • 31. Assessment of compliance with lipid guidelines in an academic medical center.
    Schwiesow SJ, Nappi JM, Ragucci KR.
    Ann Pharmacother; 2006 Jan 24; 40(1):27-31. PubMed ID: 16352778
    [Abstract] [Full Text] [Related]

  • 32. Reaching goal in hypercholesterolaemia: dual inhibition of cholesterol synthesis and absorption with simvastatin plus ezetimibe.
    Daskalopoulou SS, Mikhailidis DP.
    Curr Med Res Opin; 2006 Mar 24; 22(3):511-28. PubMed ID: 16574035
    [Abstract] [Full Text] [Related]

  • 33. Recent National Cholesterol Education Program Adult Treatment Panel III update: adjustments and options.
    Stone NJ, Bilek S, Rosenbaum S.
    Am J Cardiol; 2005 Aug 22; 96(4A):53E-59E. PubMed ID: 16098845
    [Abstract] [Full Text] [Related]

  • 34. Pharmacologic treatment of type 2 diabetic dyslipidemia.
    Moon YS, Kashyap ML.
    Pharmacotherapy; 2004 Dec 22; 24(12):1692-713. PubMed ID: 15585439
    [Abstract] [Full Text] [Related]

  • 35. The use of lipid-lowering drug therapy in children and adolescents.
    Avis HJ, Vissers MN, Wijburg FA, Kastelein JJ, Hutten BA.
    Curr Opin Investig Drugs; 2009 Mar 22; 10(3):224-31. PubMed ID: 19333879
    [Abstract] [Full Text] [Related]

  • 36. [Favorable effects of decreasing lipids in patients with diabetes mellitus].
    Gouni-Berthold I, Krone W.
    Dtsch Med Wochenschr; 2006 Dec 22; 131 Suppl 8():S252-4. PubMed ID: 17139581
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Effects of nicotinic acid and lovastatin in combination with cholestyramine in renal transplant patients.
    Lal SM, Katyal A.
    Mo Med; 2002 Dec 22; 99(10):580-4. PubMed ID: 12534147
    [Abstract] [Full Text] [Related]

  • 40. Identifying and managing patients with hyperlipidemia.
    Clark AB, Holt JM.
    Am J Manag Care; 1997 Aug 22; 3(8):1211-9; quiz 1223-5. PubMed ID: 10170303
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.